United States: Honesty Is The Best Policy: USPTO Clarifies Duties Of Disclosure And Reasonable Inquiry For Pharmaceutical Patents - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
On July 29, 2022, the United States Patent and Trademark Office (USPTO) published a notice titled "Duties of Disclosure and Reasonable Inquiry During Examination...
Full Article